These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30334577)

  • 1. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
    Lobitz S; Telfer P; Cela E; Allaf B; Angastiniotis M; Backman Johansson C; Badens C; Bento C; Bouva MJ; Canatan D; Charlton M; Coppinger C; Daniel Y; de Montalembert M; Ducoroy P; Dulin E; Fingerhut R; Frömmel C; García-Morin M; Gulbis B; Holtkamp U; Inusa B; James J; Kleanthous M; Klein J; Kunz JB; Langabeer L; Lapouméroulie C; Marcao A; Marín Soria JL; McMahon C; Ohene-Frempong K; Périni JM; Piel FB; Russo G; Sainati L; Schmugge M; Streetly A; Tshilolo L; Turner C; Venturelli D; Vilarinho L; Yahyaoui R; Elion J; Colombatti R;
    Br J Haematol; 2018 Nov; 183(4):648-660. PubMed ID: 30334577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Newborn screening for sickle cell disease in France].
    Brousse V; Allaf B; Benkerrou M
    Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
    Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
    Nnachi OC; Umeokonkwo AA; Okoye HC; Ekwe AN; Akpa CO; Okoye AE
    West Afr J Med; 2023 Mar; 40(3):298-304. PubMed ID: 37017939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D; McGann PT
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative.
    Ezenwosu OU; Olawepo JO; Lacroix-Willliamson LJ; Itanyi IU; Ogidi A; Onyeka TC; Gully M; Gregory M; Breeze JL; Ibemere S; Idemili-Aronu N; Molnar BE; Ezeanolue EE
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):321. PubMed ID: 38671412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM; Kuona P; Misihairabgwi JM
    BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.
    Archer NM; Inusa B; Makani J; Nkya S; Tshilolo L; Tubman VN; McGann PT; Ambrose EE; Henrich N; Spector J; Ohene-Frempong K
    BMJ Open; 2022 Mar; 12(3):e057623. PubMed ID: 35264367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA; St Victor Dély N; Paul Hanna M; Saint Fleur R; Cetoute M; Metalonis S; Hustace T; Brown EC; Marcelin LH; Muscadin E; Eveillard R; Lerebours E
    Blood Adv; 2024 Jan; 8(1):14-22. PubMed ID: 37820110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell screening in Europe: the time has come.
    Shook LM; Ware RE
    Br J Haematol; 2018 Nov; 183(4):534-535. PubMed ID: 30430539
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
    Lobitz S; Frömmel C; Brose A; Klein J; Blankenstein O
    Eur J Hum Genet; 2014 Aug; 22(8):1051-3. PubMed ID: 24398797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for assessing outcomes from newborn screening: on the road to measuring its promise.
    Hinton CF; Homer CJ; Thompson AA; Williams A; Hassell KL; Feuchtbaum L; Berry SA; Comeau AM; Therrell BL; Brower A; Harris KB; Brown C; Monaco J; Ostrander RJ; Zuckerman AE; Kaye C; Dougherty D; Greene C; Green NS;
    Mol Genet Metab; 2016 Aug; 118(4):221-9. PubMed ID: 27268406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Throughput Newborn Screening for Sickle Cell Disease - Application of Two-Tiered Testing with a qPCR-Based Primary screen.
    Janda J; Hegert S; Bzdok J; Tesorero R; Holtkamp U; Burggraf S; Schuhmann E; Hörster F; Hoffmann GF; Janzen N; Okun JG; Becker M; Durner J
    Klin Padiatr; 2023 Nov; 235(6):366-372. PubMed ID: 37748509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.